Real-world palbociclib effectiveness in patients with metastatic breast cancer: Focus on neutropenia-related treatment modification strategies and clinical outcomes

Real-world palbociclib effectiveness in patients with metastatic breast cancer: Focus on neutropenia-related treatment modification strategies and clinical outcomes

Introduction: In addition to clinical trials, real-world data is needed to verify the effectiveness of the CDK 4/6 inhibitor palbociclib. The primary aim was to examine real-world variation in treatment modification strategies for neutropenia and its relation to progression-free survival (PFS). The...

Full description

Bibliographic Details
Main Authors: Mariska Q.N. Hackert, Cornelia F. van Uden-Kraan, Mariette J. Agterof, Annette W.G. van der Velden, Birgit E.P.J. Vriens, Johan J.B. Janssen, Maud Geenen, Annemieke van der Padt-Pruijsten, Ewoudt M.W. van de Garde
Format: Article
Language:English
Published: Elsevier 2023-01-01
Series:Cancer Treatment and Research Communications
Subjects:
Palbociclib
Real-world
Clinical practice
Treatment modification strategies
Efficacy-effectiveness gap
Metastatic breast cancer
Online Access:http://www.sciencedirect.com/science/article/pii/S2468294223000126

Internet

http://www.sciencedirect.com/science/article/pii/S2468294223000126

Similar Items